IRIS Pharma Solutions for every challenge in ocular drug and ophthalmic medical device development   Not just an ophthalmology-focused CRO, Iris Pharma helps clients around the world navigate every stage of the drug and device development process and delivers customized solutions for:  Assessing possible therapeutic effect in ocular diseases Adding value to promising drug candidates or medical devices Designing development plans and preclinical packages and carrying out studies to proceed with confidence from bench to bedside Providing the comprehensive clinical development services you need, from First-in-Human through Phase IV and Post-marketing follow-through Iris Pharma’s a la carte services include:  in vivo  screening Proof of concept studies Ocular efficacy studies GLP preclinical studies Bioanalytical testing services Clinical trials and clinical research services Post marketing surveys We accompany start-up companies, biotechnology companies, large pharmaceutical companies, pharmaceutical labs, universities, research organizations and consultants in their ophthalmology projects.   Our assets:  30 years of experience in the field of ophthalmology research All ophthalmic indications mastered 70 FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations State-of-the-art medical and scientific equipment Highly specialized and qualified staff CIR agreement